PAR paradigm biopharmaceuticals limited..

Ann: Paradigm Secures Ethics Approval for Phase 3 Trial, page-54

  1. 44 Posts.
    lightbulb Created with Sketch. 11
    I think there is a lot of merit in what you are saying Ed. Obviously, we have the science side covered, but the communication about what we have leaves a lot to be desired sometimes. Took my mutt for his third cartrophen shot today and have been chatting with the vet about Paradigm's human trials, which she was unaware of and very interested in. She's now going to buy her first small parcel.. She was very excitedly telling me about other vets in the past who would "accidentally " fall on a cartrophen injection and swore by it!
    There are a lot of untapped investors out there who are unaware of what we have and a lot more eager potential customers to fire up
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.0¢
Change
-0.010(3.33%)
Mkt cap ! $112.9M
Open High Low Value Volume
30.0¢ 30.5¢ 29.0¢ $123.6K 421.2K

Buyers (Bids)

No. Vol. Price($)
3 36097 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 101917 1
View Market Depth
Last trade - 16.10pm 23/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.